These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mania associated with interferon alpha2b treatment. Basanth KK; Jacob R; Jacob KS J Postgrad Med; 2006; 52(3):207-9. PubMed ID: 16855324 [TBL] [Abstract][Full Text] [Related]
5. Gabapentin as prophylaxis against steroid-induced mania. Ginsberg DL; Sussman N Can J Psychiatry; 2001 Jun; 46(5):455-6. PubMed ID: 11441792 [No Abstract] [Full Text] [Related]
6. [Gabapentin in the treatment of mania]. Grunze H; Erfurth A; Amann B; Normann C; Walden J Fortschr Neurol Psychiatr; 1999 Jun; 67(6):256-60. PubMed ID: 10399045 [TBL] [Abstract][Full Text] [Related]
7. Gabapentin in the treatment of adolescent mania: a case report. Soutullo CA; Casuto LS; Keck PE J Child Adolesc Psychopharmacol; 1998; 8(1):81-5. PubMed ID: 9639083 [TBL] [Abstract][Full Text] [Related]
8. An open label study of gabapentin in the treatment of acute mania. Erfurth A; Kammerer C; Grunze H; Normann C; Walden J J Psychiatr Res; 1998; 32(5):261-4. PubMed ID: 9789203 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Perugi G; Toni C; Ruffolo G; Sartini S; Simonini E; Akiskal H Pharmacopsychiatry; 1999 Jul; 32(4):136-41. PubMed ID: 10505483 [TBL] [Abstract][Full Text] [Related]
11. Gabapentin treatment for bipolar disorders. Maidment ID Ann Pharmacother; 2001 Oct; 35(10):1264-9. PubMed ID: 11675857 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity? Perugi G; Toni C; Frare F; Ruffolo G; Moretti L; Torti C; Akiskal HS J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558 [TBL] [Abstract][Full Text] [Related]
13. The clinical use of gabapentin in bipolar spectrum disorders. Carta MG; Hardoy MC; Hardoy MJ; Grunze H; Carpiniello B J Affect Disord; 2003 Jun; 75(1):83-91. PubMed ID: 12781355 [TBL] [Abstract][Full Text] [Related]
14. [Alpha-interferon and mental disorders]. Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D Encephale; 2001; 27(4):308-17. PubMed ID: 11686052 [TBL] [Abstract][Full Text] [Related]
15. Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders. Navinés R; Gómez-Gil E; Puig S; Baeza I; De Pablo J; Martín-Santos R Eur J Dermatol; 2009; 19(6):611-5. PubMed ID: 19709980 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324 [TBL] [Abstract][Full Text] [Related]
17. Gabapentin augmentation therapy in bipolar depression. Wang PW; Santosa C; Schumacher M; Winsberg ME; Strong C; Ketter TA Bipolar Disord; 2002 Oct; 4(5):296-301. PubMed ID: 12479661 [TBL] [Abstract][Full Text] [Related]
18. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950 [TBL] [Abstract][Full Text] [Related]